Molecular investigations reveal that let‐7a exerts its tumor‐suppressive effects by targeting multiple oncogenes, including high mobility group AT‐hook 2 (HMGA2) and cyclin D1 (CCND1) [95]. The gene discussed is CCND1; the disease is neoplasm.